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COVID-19 is an infectious disease caused by severe 
acute respiratory syndrome corona virus 2 (SARS-CoV-
2). The disease has been first identified in December 
2019 in Wuhan, and has since spread globally, 
resulting in the on-going 2019-20 corona virus 
pandemic. Almost 80 percentages of the patients 
show     mild      symptoms      whereas       20      needs 
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hospitalization and only 5 percentages of the patients 
require intensive care.  
According to the US CDC, symptoms present at onset 
of COVID-19 are highly variable. However, in the stage 
of full-blown disease, 83-99%  of patients develop 
fever, 59-82% have, dry cough, 44 – 77% have fatigue, 
40 - 84 % have anorexia,31 -40% patients have 
shortness of breath, 28 – 33% patients  havesputum 
production and 11 – 35 % of the patients have 
myalgia.[1] 
Out of that fever, sore throat and dry cough are 
considered as cardinal symptoms of the disease. CDC 
further added chill, headache, tastelessness. In some 
of cases diarrhoea,[2]  haemoptysis[3] like atypical 
symptoms are also found. But these are seen only in 
less than 10% of the cases. Same way skin eruptions 
also found in more or less the same number of 
cases.[4] On the basis of the symptoms the whole 
disease may be categorized in three stages like; 
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COVID-19 is an infectious disease and has become pandemic since early 2020. Researches are on-
going for vaccine of the disease. World Health Organization is working with research institutions to 
select traditional medicine products that can be investigated for clinical efficacy and safety from the 
disease. Aim: To evaluate efficacy of Ayurvedic line of management in COVID-19 patients. Material 
and Methods: 15 patients with RT PCR positive for corona virus positive and having mild to moderate 
symptoms of the disease and willing to participate in the study were recruited for the trial. Registered 
patients were given Sanjeevani Vati 250 mg thrice a day after meal with honey, Gojihvadi Kwatha 20 
ml twice on empty stomach and Panchagavya Granules 10 gm with 100 ml of milk after breakfast and 
dinner were given till disappearance of all the symptoms of COVID-19. If patient does not respond to 
the medication were allowed to leave the treatment in between. Result: out of 15 patients 14 were 
successfully treated with Ayurvedic management and remained asymptomatic latest on 12th day of 
medication. Average time was taken to normalize the temperature 4.22 (+2.41) days, dry cough 
9.83rd days (+2.15) and body ache took maximum time to disappear i.e. 10.66th (+0.25) day. 
Conclusion: Ayurvedic formulations along with Panchgavya can successfully be implemented in mild 
to moderate cases of COVID 19. 
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▪ Mild to moderate (mild symptoms up to mild 
pneumonia): 81% of the patients 
▪ Severe (difficulty in breathing, hypoxia, or >50% 
lung involvement on imaging): 14% of the patients 
▪ Critical (respiratory failure, shock, or multi-organ 
system dysfunction): 5% 
As per the disease outbreak and presentation; current 
situation can be compared with Janapadodhvamsa, 
that mass level population gets affected within short 
period of time.[5] Disease presentation wise it can be 
put under the heading of Vayu-Kapha predominant 
Pitta associated Sannipataja Jwara.  
WHO is working with research institutions to select 
traditional medicine products that can be investigated 
for clinical efficacy and safety for COVID-19 
management.[6]  As per one article Chinese TCM 
played a vital role to cure the COVID-19 patients in 
china.[7] Same way EHO also supports use of TCM, 
CAM in the management of COVID-19.[8] 
As far as Ayurvedic management of Sannipataja Jwara 
is concern, it should be treated on the basis of 
predominant Dosha, not harming the other body 
tissues of the body as well as not crossing line of 
management of Jwara.[9] 
AIMS AND OBJECTIVES 
To evaluate efficacy of Ayurvedic line of management 
in COVID-19 patients. 
MATERIALS AND METHODS 
▪ Study type: Interventional,  prospective, multi 
centric clinical trial 
▪ Purpose: Treatment 
▪ Masking: Open labelled  
▪ End Point:  
1. Primary end point - subjective improvement 
2. Secondary end point - Get free from condition 
▪ Time duration:  till the subject gets symptoms 
free  
Selection criteria 
The patients have mild to moderate symptoms like 
fever, dry cough, pain in throat, body ache, dizziness 
etc. having COVID-19 tested positive and willing to 
participate in the study were selected for present 
study.  
Inclusion Criteria 
▪ COVID-19 positive patients having mild to 
moderate symptoms.  
▪ Patients of either sex. 
▪ Patients age 12 years and above 
▪ Patient willing to participate 
Exclusion Criteria 
▪ High grade fever (Temperature > 103 F) 
▪ SPO2 level < 92 
▪ Breathing difficulty, chest pain on deep breath 
▪ patient having any of co morbidity like 
uncontrolled HT or DM, Bronchial asthma,  CKD or 
liver diseases 
▪ Age below 12 years  
▪ patients who requires intensive care / ventilator  
Assessment criteria 
All the patients were assessed as per the CRF – COVID 
19, prepared by AYUSH.[10] 
Medicine protocol used for the present clinical trial 
Sanjeevani Vati[11] is indicated for Sannipataj Jwara as 
well as an easy available formulation. Gojihvadi 
Kwatha[12] is a useful formulation for respiratory 
system. Panchgavya Ghrita is indicated as one of 
formulation for Sannipataja Jwara[13] especially fevers 
those are exogenous in origin. Taking into 
consideration above fact these above three 
formulations were selected for present clinical trial as 
primary protocol. Taking in to consideration 
palatability of the medicine granules were prepared 
from Pacha Gavya Ghrita. (Table 1) 
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Table 1: Posology 
Formulation  Saneevani 
vati 
Gojihvadi 
Kwatha     
Panchagavya 
Granules* 
Dose   1 tablet 
(250mg each) 
Three time a 
day after meal 
20 ml twice a 
day empty 
stomach.         
       
10 grams 




Anupana Warm water Warm water With milk 
twice a day 
Duration Till recovery from the symptoms 
Sanjeevani Vati was prepared by M/s Nagarjun 
pharmacuticals Pvt. Ltd. Ta. Kalol, Dist. Gandhinagar. 
Gojihvadi Kwatha and Panchagavya Granules were 
prepared by Shree Kamadhenu Divya Aushadhi Mahila 
Sahakari Mandala, At & Po Ishwariya, Ta. & Dist. 
Jamnagar.  
Table 2: Panchagavya Granules each 10gm granules 
contain. 
Ingredient Proportion  
Panchagavya Ghrita 1.5gm 
Milk powder  3.3gm 
Coco powder 0.2gm 
Lump sugar  5gm 
Do’s and Don’ts 
All the patients were advised to take light food. They 
also instructed to have ginger powder 1 gm. twice 
after meal daily. As well as lime juice (5 to 10 drops) 
with a glass of water daily. 
Withdrawn criteria 
If patient does not respond to the medicine and 
symptoms intensify persist, develops serious 
condition (like high grade fever, reduction in SPO2 
level) the patients were free to withdraw from the 
trial and shifted to hospital for further management. 
All the patients were free to withdraw themselves 
from present clinical trial if they feel so. 
Data collection method 
All the recruited were home isolated after confirmed 
COVID-19 positive and were contacted daily by 
telephone, and case report format were filled on daily 
basis. 
OBSERVATION 
Status of the patient 
The study was conducted during July and August 
2020. Total 15 RT-PCR tested COVID-19 positive 
patients were recruited in this trial after taking their 
consent. Out of those 14 patients completed the trial 
and cured successfully whereas one subject 21 year 
male patient developed breathing difficulty with low 
level SPO2 on 3rd day of the treatment and hence was 
hospitalized. 
Out of the registered patients, 9 (60%) were male 
followed by female 6 (40%). Maximum age of the 
patient was 57 years whereas minimum age was 9 
years. None of the patients was health care worker 
and only three patients (20%) had history of domestic 
travelling within last 14 days. 
Two patients took tab. Paracetamol 500 mg thrice a 
day for first two days along with vitamin B complex 
and vitamin C tablet for seven days. 
Maximum 9 (60 %) patients had self-reported fever 
(average temperature-100.5˚F), followed by dry cough 
6pts. (40%) patients, body ache 6 pts. (40%), 
weakness 2 pts. (13.33%). Sore throat, loose motion, 
not to have taste, headache and nausea, each was 
found in one patient (6.66%) each. In this recruited 
patients only one patient had Type - 2 Diabetes 
Mellitus as comorbidity. (Chart: 1) 
Average time was taken to normalize the temperature 
was 4.22 (+2.41) days. Dry cough was disappeared on 
9.83rd day average (+2.15) days. Body ache took 
maximum time to disappear i.e. 10.66th(+0.25) day. 
Loose motion found only in one patient and that was 
started to reduce on day 6th and returned to normal 
consistency on day 7th. Same way sore throat, 
headache, tastelessness and nausea was observed in 
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one patient each and that was disappeared on 9th, 
10th, 9th and 8th day respectively. (Chart: 2) 
All (14) patients become symptom free latest by 12th 
day of medication. Out of those 14 patients, 7 
subjects underwent for RT - PCR after completion of 
medication and all those remained negative for the 
same. 
DISCUSSION 
As per the presentation, COVID-19 resembles with 
Kapha-Vayu predominant exogenous type of 
Sannipataja Jwara, hence it should be treated in the 
line of the management of the same. Sanjeevani Vati 
is a unique formulation mentioned in Sharangdhara 
Samhita where its indications are Sannipatja Jwara, 
Atisara, Ajeerna as well as snake bite in different 
dosage. Hence it may act to break pathogenesis of 
such condition where all three Dosha are involved. 
Simultaneously ingredients of  Gojihvadi Kwatha 
specially useful for dry cough as its almost ingredients 
having soothing effect also, that may have prevented 
the system from further damage and recovered the 
patients within time. Pancha Gavya granules contain 
Pancha Gavya Ghee. It is one of the unique 
formulation for Sannipataja Jwara itself especially 
exogenous in origin[14] ingredients of Pancha Gavya 
are cow dung, cow urine, cow milk, curd prepared 
from cow milk and ghee prepared from cow milk. 
Here interesting thing is, the formulation is not 
mentioned in Jwara Chikitsa Adhyaya but it is said 
that “the formulations said for disease of psyche are 
to be used for Sannipataja Jwara” such formulations 
should have Sukshma property that can reach up to 
cellular level within short period of time. This is the 
hypothesis that 14 out of 15 patients treated 
successfully and gradual reduction of symptoms was 
noted. Further Cow dung as well as cow urine has 
Sharma property means it purify body tissue[15] hence 
it provide health and prevent body tissues from 
further damage. By this property it may be helpful the 
patients to check the progress of the disease and 
revert the symptoms by detachment of Dosha and 
Dushya from each other and hence Vighatana of the 
Samprapti. 
Though the sample size is less hence it needs more 
data to conclude, but still the results are encouraging 
and hence may be implemented on large scale. 
CONCLUSION 
Ayurvedic management protocol for COVID-19 
patients is effective for mild to moderate type of 
SARCE COV-2 patients. 
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